Author
Listed:
- Joshua Ames
(University of Illinois at Chicago, College of Medicine
University of Illinois at Chicago, College of Medicine)
- Tejabhiram Yadavalli
(University of Illinois at Chicago, College of Medicine)
- Rahul Suryawanshi
(University of Illinois at Chicago, College of Medicine)
- James Hopkins
(University of Illinois at Chicago, College of Medicine
University of Illinois at Chicago, College of Medicine)
- Alexander Agelidis
(University of Illinois at Chicago, College of Medicine
University of Illinois at Chicago, College of Medicine)
- Chandrashekhar Patil
(University of Illinois at Chicago, College of Medicine)
- Brian Fredericks
(University of Illinois at Chicago, College of Medicine)
- Henry Tseng
(Duke Eye Center and Department of Ophthalmology, Duke University Medical Center)
- Tibor Valyi-Nagy
(University of Illinois at Chicago, College of Medicine)
- Deepak Shukla
(University of Illinois at Chicago, College of Medicine
University of Illinois at Chicago, College of Medicine)
Abstract
Fast-replicating neurotropic herpesviruses exemplified by herpes simplex virus-1 (HSV-1) naturally infect the central nervous system (CNS). However, most individuals intrinsically suppress the virus during a primary infection and preclude it from significantly damaging the CNS. Optineurin (OPTN) is a conserved autophagy receptor with little understanding of its role in neurotropic viral infections. We show that OPTN selectively targets HSV-1 tegument protein, VP16, and the fusion glycoprotein, gB, to degradation by autophagy. OPTN-deficient mice challenged with HSV-1 show significant cognitive decline and susceptibility to lethal CNS infection. OPTN deficiency unveils severe consequences for recruitment of adaptive immunity and suppression of neuronal necroptosis. Ocular HSV-1 infection is lethal without OPTN and is rescued using a necroptosis inhibitor. These results place OPTN at the crux of neuronal survival from potentially lethal CNS viral infections.
Suggested Citation
Joshua Ames & Tejabhiram Yadavalli & Rahul Suryawanshi & James Hopkins & Alexander Agelidis & Chandrashekhar Patil & Brian Fredericks & Henry Tseng & Tibor Valyi-Nagy & Deepak Shukla, 2021.
"OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25642-z
DOI: 10.1038/s41467-021-25642-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25642-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.